Latest Breaking News On - Akoya bioscience - Page 3 : comparemela.com

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Akoya biosciencePriyam shahAkoya biosciencesDigital healthAkoya biosciences incSpatial biology companySpatial biologyLife scienceDiagnostic tools conference

Akoya Biosciences Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases -January 18, 2024 at 08:02 am EST

Akoya Biosciences Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases -January 18, 2024 at 08:02 am EST
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Akoya biosciencesArutha kulasingheAkoya bioscienceBrian mckelligonPriyam shahJohn fraserQueensland spatial biology centreWesley research instituteExchange commissionSpatial biology companyHarvard medical schoolAkoya biosciences incYale universityJude children research hospitalSpatial biologyProfessor john fraser

Akoya Biosciences, Inc s (NASDAQ:AKYA) market cap touched US$254m last week, benefiting both private equity firms who own 48% as well as institutions

Key Insights Significant control over Akoya Biosciences by private equity firms implies that the general public has.

Akoya bioscienceAkoya biosciencesAkoya biosciences incTelegraph hill partnersPrivate equity firmsNstitutional ownership

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

MaxFuse enables matching and integration of datasets from spatial proteomics, spatial transcriptomics, single-cell sequencing, or other modalities Development and application of MaxFuse were.

Zongming maGarry nolanNancy zhangPriyam shahAaron mayerAkoya bioscienceAkoya biosciencesExchange commissionAkoya biosciences incUniversity of pennsylvaniaGlobenewswire incSpatial biology companyEnable medicineNature biotechnologyChief scientific officerPowered tissue atlas

Akoya Biosciences Announces Preliminary Financial Results

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced.

Brian mckelligonAkoya biosciencePriyam shahAkoya biosciencesSpatial biology companyExchange commissionAkoya biosciences incChief executive officerFinancial conditionNasdaq akyaAkoya biosciences